Related Experiment Video
Updated: Sep 28, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
E2F4 loss suppresses tumorigenesis in Rb mutant mice
Eunice Y Lee1, Hieu Cam, Ulrike Ziebold
1Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Abstract:
The E2F transcription factors mediate the activation or repression of key cell cycle regulatory genes under the control of the retinoblastoma protein (pRB) tumor suppressor and its relatives, p107 and p130. Here we investigate how E2F4, the major "repressive" E2F, contributes to pRB's tumor-suppressive properties. Remarkably, E2F4 loss suppresses the development of both pituitary and thyroid tumors in Rb(+/-) mice. Importantly, E2F4 loss also suppresses the inappropriate gene expression and proliferation of pRB-deficient cells. Biochemical analyses suggest that this tumor suppression occurs via a novel mechanism: E2F4 loss allows p107 and p130 to regulate the pRB-specific, activator E2Fs. We also detect these novel E2F complexes in pRB-deficient cells, suggesting that they play a significant role in the regulation of tumorigenesis in vivo.
Insights
Loss of E2F4, a key repressive transcription factor, prevents tumor development in mice lacking the retinoblastoma protein (pRB). This occurs through a novel mechanism involving p107 and p130 regulating other E2F factors.
Area of Science:
- * Molecular Biology
- * Cancer Biology
- * Genetics
Background:
- * E2F transcription factors regulate cell cycle genes.
- * Retinoblastoma protein (pRB) and its relatives (p107, p130) are tumor suppressors.
- * E2F4 is a major repressive E2F family member.
Purpose of the Study:
- * To investigate the role of E2F4 in pRB's tumor-suppressive function.
- * To understand the mechanism by which E2F4 loss impacts tumorigenesis.
Main Methods:
- * Analysis of Rb(+/-) mice with and without E2F4.
- * Biochemical analyses of E2F complexes.
- * Assessment of gene expression and cell proliferation in pRB-deficient cells.
Main Results:
- * E2F4 loss significantly suppressed pituitary and thyroid tumor development in Rb(+/-) mice.
- * E2F4 deficiency prevented aberrant gene expression and proliferation in pRB-deficient cells.
- * A novel mechanism was identified where E2F4 loss enables p107 and p130 to regulate pRB-specific activator E2Fs.
Conclusions:
- * E2F4 plays a critical role in pRB-mediated tumor suppression.
- * Novel E2F complexes involving p107/p130 and activator E2Fs are important in regulating tumorigenesis.
- * Targeting E2F4 could be a therapeutic strategy for pRB-deficient cancers.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Negative Regulator Molecules

